Sign in
APX3330, an Oral Drug in Trial for DR and DME, Demonstrated a Favorable Safety and Tolerability Profile in Multiple Phase 1 and 2 Studies
Michael J Allingham, MD, PhD
Annual Meeting Talks
2021
Assessment of Progression of Geographic Atrophy in the FILLY Study
David R Lally, MD
On Demand Cases, Courses, and Papers
2020
Episode 31- FLUID Study - Dr. Robyn Guymer
Keyvan Koushan, MD, FRCSC
Member Podcasts
2019
Category: AMD-Neovascular